Compound LM9, a novel MyD88 inhibitor, efficiently mitigates inflammatory responses and fibrosis in obesity-induced cardiomyopathy

por Zheng, Xu-yong, Sun, Chu-chu, Liu, Qian, Lu, Xiao-yao, Fu, Li-li, Liang, Guang, Zhang, Xiu-hua, Chen, Gao-zhi
Publicado 2020